Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2019	Jun. 30, 2018		Jun. 30, 2017
Operating activities
Net loss	[1]	$ (32,488)	$ (40,834)	[2]	$ (29,536)	[2]
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense		8,299	9,876	[2]	10,162	[2]
Depreciation and amortization		3,980	3,609	[2]	2,647	[2]
Deferred rent reversal due to lease termination		0	(538)	[2]	0	[2]
Tenant improvement allowance recognition due to lease termination		0	(582)	[2]	0	[2]
Goodwill impairment		2,556	2,666	[2]	0	[2]
Accretion of net premium on short-term investments		(30)	192	[2]	403	[2]
Bad debt expense		10	(24)	[2]	189	[2]
Loss (gain) on disposal of property and equipment		(7)	15	[2]	(14)	[2]
Unrealized gain on investments		(1,174)	0	[2]	0	[2]
Changes in operating assets and liabilities:
Accounts receivable		(29,651)	11,708	[2]	(15,807)	[2]
Deferred income taxes		(94)	52	[2]	(239)	[2]
Deferred costs		(21,377)	(22,999)	[2]	(19,814)	[2]
Prepaid expenses and other current assets		(241)	76	[2]	1,113	[2]
Other assets		47	(1,300)	[2]	483	[2]
Trade accounts payable		4,005	6,836	[2]	1,195	[2]
Accrued expenses and other liabilities		12,124	(12,789)	[2]	13,854	[2]
Income taxes payable		583	23	[2]	109	[2]
Deferred rent		375	1,178	[2]	66	[2]
Deferred revenue		60,597	35,424	[2]	24,034	[2]
Net cash provided by (used in) operating activities		7,514	(7,411)	[2]	(11,155)	[2]
Investing activities
Purchases of property and equipment		(1,399)	(4,648)	[2]	(1,225)	[2]
Purchases of short-term investments		(45,816)	(49,287)	[2]	(64,957)	[2]
Proceeds from sales and maturities of short-term investments		43,737	58,404	[2]	74,878	[2]
Proceeds from sales of long-term investments		0	0	[2]	246	[2]
Net cash provided by (used in) investing activities		(3,478)	4,469	[2]	8,942	[2]
Financing activities
Proceeds from exercise of stock options		8,853	681	[2]	2,738	[2]
Repurchase of common stock		(1,303)	0	[2]	0	[2]
Tax withholdings related to net share settlements of restricted stock units		(1,982)	(2,327)	[2]	(3,008)	[2]
Net cash provided by (used in) financing activities		5,568	(1,646)	[2]	(270)	[2]
Effect of exchange rate changes on cash and cash equivalents		(478)	529	[2]	183	[2]
Net increase (decrease) in cash and cash equivalents		9,126	(4,059)	[2]	(2,300)	[2]
Cash and cash equivalents, at beginning of period	[2]	20,099	24,158		26,458
Cash and cash equivalents, at end of period		29,225	20,099	[2]	24,158	[2]
Supplemental disclosure of cash flow information
Income taxes paid (received), net		1,128	1,053	[2]	1,872	[2]
Non-cash transfer of non-marketable equity securities to short-term investments		1,348	0	[2]	0	[2]
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets
Total cash, cash equivalents and restricted cash		$ 29,225	$ 20,099	[2]	$ 26,458	[2]

[1] See Note 1 for a summary of adjustments. The cumulative effect adjustment to Accumulated Deficit and Total Stockholders' Equity related to the adoption of ASU No. 2014-09 (Topic 606) as of June 30, 2016 was $11.8 million.

[2] See Note 1 for a summary of adjustments.